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ABSTRACT 
Here we report  the influence of aging on multiple markers of oxidative-
nitrosative stress in the heart of adult (6-month), aged (30-month) and very aged (36-
month) Fischer 344/NNiaHSd X Brown Norway/BiNia (F344/NXBN) rats.  Compared to 
6 month old rat hearts, indices of oxidative (superoxide anion (–O2·), 4-hyrdoxy-2-
nonenal (4-HNE)) and nitrosative (protein nitrotyrosylation) stress were 34.1 ± 28.1%,  
186 ± 28.1% and 94 ± 5.8% higher, respectively, in 36-month hearts and these findings 
were highly correlated with increases in left ventricular wall thickness (r>0.669; r>0.710 
and p<0.01, respectively).  Regression analysis showed that increases in cardiac 
oxidative-nitrosative stress  with aging were significantly correlated with changes in the 
expression and/or regulation of proteins involved in transcriptional (NF-κB) activities, 
signaling (mitogen activated protein kinases along with Src), apoptotic ( Bcl-2, Traf-2), 
and cellular stress (HSPs).  These results suggest that the aging F344/NXBN heart may 
be highly suited for unraveling the molecular events that lead to age-associated 
alterations in cardiac oxidative stress. 
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Chapter 1 
Introduction 
 
 The development of science and modern medical technology has resulted in 
longer life spans and therefore, the aged population is increasing exponentially[1]. 
However, according to the Center of Disease Control (CDC), approximately 80% of aged 
populations have at least one chronic condition, and 50% have at least two conditions 
resulting in the majority of developed countries facing serious health concerns including 
cancers, cardiovascular diseases, metabolic disorder, and neuromuscular impairment. 
Within a few decades, the burden of health care costs will inflate colossally due to the 
increasing demands of the elderly population[2].  
 Aging, defined as a gradual decline of the fighting ability of the organism against 
stress, damage and diseases, is intuitively considered invincible; however recent studies 
are attempting to shed new light on some of the possible mechanisms of aging[3-5]. One 
of the most well known theories is oxidative stress theory which indicates that the 
overproduction of free radicals damage lipids, proteins, and DNA during respiration[4, 
5]. Since Harman proposed the free radical theory of aging a half century ago,  there has 
been  growing evidence that suggests reactive oxygen species may play a crucial role in 
aging[3, 6-8]. 
 Reactive oxygen species are a family of free radicals including superoxide (·O2-), 
hydroxyl radical (OH·) and hydrogen peroxide (H2O2) that are produced as a result of 
cellular metabolism such as respiration[5]. Although reactive oxygen species are 
produced in approximately 1 to 2 % of consumed oxygen during the respiration, under 
normal physiological conditions, superoxide (·O2-) is converted to the H2O2 by the 
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superoxide dismutase (SOD) and eventually the H2O2 is converted in to H2O with 
presence of the catalase and glutathione peroxidase[9]. Yet, abnormal oxidative stress 
that is caused by the accumulation of free radicals may play a role in the initiation or 
progression of chronic diseases such as metabolic syndrome, type II diabetes, cancer, and 
neurological disorders [5, 10-12]. Although the exact mechanism of redox disruption is 
not clear, the free radical theory points out increased amounts of superoxide (·O2-) and 
deceased amounts of nitric oxide formation (NO) or its bioavailability with aging as 
strong candidates[3]. Whether the disruption of redox balance is caused by 
overproduction of ROS, antioxidant deficiency, or a combination of the two, it will result 
in serious damage to the cell which may eventually lead to chronic diseases or aging.  
  Nevertheless, these reactive oxygen species, under ideal circumstances, can have 
a positive effect on organisms. For instance, reactive oxygen species, ·O2- , NO are 
intentionally formed to regulate cell signal process[13-15]. Specifically, several cell 
signal transductions may require the involvement of ROS-dependent activation to 
regulate a variety of cellular function such as cell signaling, metabolic, apoptotic, and 
transcriptional activities[15-17].  
Although ROS seem to play a crucial role in cardiac ischemic and reperfusion 
injury and possibly the initiation of arrhythmias[18], how ROS might induce these events 
and also the normal level of ROS needed for cell signal transduction remain unknown. A 
recent study has shown that a strong association exists between the amount of ROS and 
aging in the F344/NXBN rat aorta and this increased ROS was correlated with the 
expression of several proteins[19].  Ushio-Fukai, M., et al found the H2O2 is associated 
with the phosphrylation of p42/44 mitogen-activated protein kinases (MAPK) and p38 
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MAPK in vascular smooth muscle cell[20]. On the other hand, AMP activated protein 
kinase (AMPK) which is known to play a key role in the metabolic regulation, and  a 
study performed with cell culture suggest that intracellular ROS may activate AMPK in 
adipose cells[21]. Nuclear factor kappa beta (NF-κB) may suppress the accumulation of 
ROS that mediates an additional protective activity[22]. Transient oxidative stress 
contributes to progressive apoptosis that results in chronic condition[23].  
Considering these studies, ROS are definitely involved in the cell signal 
transduction both intentionally and unintentionally, which may cause either beneficial or 
detrimental results. Previous study using the Fischer 344/NNiaHSd X Brown 
Norway/BiNia (F344/NXBN) rat has demonstrate that aged F344/NXBN rat aorta was 
significantly correlated with ROS and several signal molecules, nevertheless it is not 
known whether a similar correlation exists in the F344/NXBN rat cardiac muscle[19]. 
Thus, this study was conducted to determine whether aging affects the presence of ROS 
in the rat heart, and secondly, to establish the correlation among ROS and signal 
molecules that may be associated with oxidative stress and morphological alterations. 
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Hypothesis/Purpose of study 
 The purpose of this study was to determine how aging affects multiple, 
previously identified markers of oxidative-nitrosative stress in the rat heart.  We 
hypothesized that aging would be associated with increases in the cardiac content or basal 
phosphorylation of oxidative-nitrosative stress markers.   
 
Specific Aim 1 
To determine if aging in the F344/NXBN heart is associated with increased ROS.  
Hypothesis 
We hypothesize that aging will be associated with increased indices of cardiac 
ROS.  
 
Specific Aim 2 
To determine how aging affects multiple, previously identified markers of oxidative-
nitrosative stress in the F344/NXBN rat heart.  
Hypothesis 
We hypothesize that age-associated increases in ROS will be strongly associated 
with indices of oxidative-nitrosative stress in the aging F344/NXBN heart.  
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Significance of the study 
 Increased age is the primary risk factor for the development of cardiac and 
vascular disease. It is theorized that the initiation and progression of aging is strongly 
related to ROS, however the molecular target(s) of ROS remains to be elucidated. A 
better understanding of the relationship between aging and cardiac ROS may provide 
insight into how aging may affect cardiovascular structure, function and disease 
development.  
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Chapter 2 
Review of Literature 
This chapter will describe the literature regarding age associate cardiovascular 
alteration, ROS, and ROS in the cardiovascular system.  
 
Age associated cardiovascular change 
  
One of the highest causes of death in the aged population is cardiovascular 
diseases that include coronary artery atherosclerosis, hypertension, chronic heart failure, 
and congestive heart failure. Recent studies have found that the elderly population 
experiences the following cardiovascular related changes; left ventricular hypertrophy 
(LVH), altered hemodynamic, arrhythmia, and valvular disease[24, 25]. Specifically, 
even with the absence of disease conditions,  the aged heart revealed modest increases in 
heart mass, particularly in left ventricular and interventricular septal wall thickness  
because of the increased size of myocytes[26]. A major issue in common age associated 
hemodynamic changes is isolated systolic hypertension due to increased systolic blood 
pressure and decreased diastolic blood pressure[27]. Additionally, altered ventricular 
relaxation and abnormal ventricular filling are the hallmarks of diastolic heart failure[28]. 
As a compensatory mechanism of hypertension, LVH is common in patients with high 
blood pressure. Atrial Fibrillation(AF), represented by atrial depolarization issues, one of 
the common arrhythmia seen in elderly polulation[29], may be caused by a calcification 
of the atrioventricular(AV) node, AV bundle, and left/right bundle branches which 
contributes to the arrhythmia as well as a marked decrease in pacemaker cells in the 
sinoatrial(SA) node with advanced aging[26].  Finally, aged population also demonstrates 
 7
degenerative valvular processes which commonly appear  in both the aortic and mitral 
valves[30]. Although it is well described that these changes happen in most aged 
individuals, the mechanisms of these alterations at the molecular level are not elucidated.  
Age associated cardiovascular alteration studies using human subjects exist(e.g. 
the Baltimore Longitudinal Study on Aging)[31],  however,  human aging studies are 
challenging because of the limitation of non-invasive procedure, setting a cross sectional 
design, and controlling confounding variable limit availability. Because these limitations 
are relatively controllable in animal studies, cellular and molecular mechanisms that 
emphasize age associated cardiovascular changes can be examined. For instance, age 
related decline in force production and motility activity that may be the result of 
oxidative damages are present in aged Fischer 344(F344) rats muscle[32, 33]. 
Additionally, age dependent increase in 3-nitrotyrosine content in F344 skeletal muscles 
are increased in  proteins involved in metabolism and calcium homeostasis such as 
sarcoplasmic reticulum Ca(+2)-ATPase, aconitase, beta-enolase, triosephosphate 
isomerase, and carbonic anhydrase III[34].  
Although F344 rat model are frequently used for aging studies, the hybrid of 
F344/NXBN model exhibits significantly fewer pathological conditions, and a greater 
mean age of 50 % of mortality[35]. Therefore, this hybrid model is recommended by the 
National Institutes on Aging for aging studies. Recently a study demonstrated the 
reference values for cardiac structure and function in the aging F344/NXBN rat 
model[36]. Similar to humans, these age-associated changes included increases in left 
ventricular mass, left ventricular mass/body weight ratio, posterior wall thickness/body 
weight ratio, anterior thickness/body weight ratio, and left ventricular chamber 
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diameter/body weight ratio. Taken together, these data suggest the aging F344/NXBN rat 
model exhibits cardiac alterations with aging very similar to what is seen in humans.  
In the conclusion, aging seems to be a major risk of cardiovascular disease. A 
tremendous amount of studies have described alteration in the cardiovascular structure 
and function with aging, nevertheless, the mechanisms behind the alteration remains 
undetermined. Although applications of the result from animal studies are limited, similar 
age associated physiological alterations reveal great potential for future applications to 
human physiology.  
 
Reactive Oxygen Species (ROS) 
A chemical process wherein a substance gains an electron is defined as reduction, 
whereas the opposite process of losing an electron is classified as oxidation. Biologically, 
the compound that acts as a reducing agent is termed an antioxidant, on the other hand, 
the compound that acts as an oxidant is referred to as a pro-oxidant[37]. ROS pro-
oxidants can be classified into two subcategories which include radical and nonradical 
types.  A radical is a species with an odd number of electrons in the shells such as 
superoxide radical (O•-), nitric oxide radical (NO•), hydroxyl radical (OH•-), peroxyl 
(ROO•-) and alkoxyl (RO•-) radicals[37]. Typically, these species possess very reactive 
characteristics due to the presence of an unpaired electron in the shell. Nonradical species 
do not contain an unpaired electron such as hypochlorous acid (HClO), hydrogen 
peroxide (H2O2), Ozone (O3) and so on. Nevertheless, some of them are extremely 
reactive.  
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ROS are known to come from two major categories including endogenous and 
exogenous sources. The exogenous factors include γ-, UV-irradiation, ultrasound, food, 
drugs, pollutants, Xenobiotics and toxins while endogenous factors are comprised of 
neutrophils, enzymes, and mitochondria[37]. Within these potential sources of ROS, it is 
thought that increased NAD(P)H oxidase or alterations in mitochondrial function may be 
the central cause of enhanced ROS generation in the aged heart[38]. Although there are 
many approaches to evaluate the existence of ROS in biochemical reactions, the only 
direct ways to measure ROS are electron spin resonance that measures relatively stable 
radicals, and the spin trapping method[37]. However, due to the difficulty of direct ROS 
detection, the quantification of oxidative damage markers known as the fingerprint 
method is often utilized. As an example of the introduction of carbonyl group is often 
used as an indices of ROS level [39, 40]. Additionally, when excessive superoxide and 
nitric oxide are present, it can produce highly reactive peroxynitrite that can disturb 
homeostatic regulation by interacting with macromolecules.[37] Therefore, measuring 3-
nitrotyrosine is often employed to indicate the nitration of tyrosine residue caused by 
nitorosative stress[41]. Generally, the end products of the macromolecules that interact 
with ROS indicate the existence of ROS.  
 
Aging and ROS 
The wish to be young and healthy is common to all, but morphological and 
functional alterations are inevitably exhibited as one ages. It is obvious, but no one can 
avoid death. Therefore, the goal of aging research is to understand the mechanism of the 
decline of physical function that appears with aging and, hopefully, to delay its progress. 
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In gerontology, many theories have been proposed to explain the diversity of the aging 
process in nature. Generally speaking, theories of aging are categorized into two major 
groups that are composed of several subdivisions. One of the major theories is the 
programmed theory that explains aging is regulated by the genes based on a biological 
timetable[42, 43]. Another is error or damage theory that focuses on environmental 
assaults to the system[8]. Although those two theories contain further branches of 
theories, many of these theories are not mutually exclusive[44].  
ROS may be an important initiator and mediator of a variety of chronic conditions 
such as cancers, neuromuscular dysfunctions, pulmonary disorders and cardiovascular 
diseases[45-48]. Similarly, the free radical theory of aging explains that the progression 
of aging happens at the biochemical level [49]. Both decreased antioxidant activities, and 
increased ROS production may lead to an accumulation of free radicals that cause 
oxidation of proteins, nucleic acids, and lipids[39]. In the last third of lifespan, 
tremendous increases in the modification of side chain proteins, known as carbonyl 
content, has been shown from tissue in a variety of species[40]. Additionally, one third of 
these modified proteins are likely to be dysfunctional enzymes or structural proteins.  
Although the exact role of ROS still remains to be elucidated, growing evidence 
suggests that ROS may play a crucial role in multiple cell signal transductions[50]. 
Indeed, the cell posses a system to detect and correct alterations from variety of stressors, 
including oxidative stress. Nevertheless, if proteins experience excessive ROS, protein 
degradation and fragmentation may result which will eventually lead to physiological 
changes.   
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ROS and cardiovascular disease  
Smooth muscle cells proliferation and hypertrophy are due, at least in part, to the 
increased ROS that may regulate mitogenesis and apoptosis in vascular smooth muscle 
and endothelial cells[51]. It is known that ROS mediated MAPK activation is involved in 
smooth muscle cell hypertrophy and inhibition of MAPK by antioxidants may affect 
signal transduction[52]. A recent study suggests that vascular aging in the F344/NXBN 
rat is associated with an increase in superoxide which is highly correlated with changes in 
aortic morphology, total protein nitration and changes in the expression and/or regulation 
of proteins involved in metabolic (AMPK-α), signaling (mitogen activated protein 
kinases along with c-Src), apoptotic (Bax, Bcl-2, Traf-2), and transcriptional (NF-κB) 
activities[19]. These data suggest that age associated alterations such as morphology and 
signal transduction in smooth muscle are related to ROS.  
In cardiac muscle, cardiomyocyte hypertrophy may be caused by angiotensin II 
through the ROS mediated activation of AP-1[53].  Additionally, rat myocytes exposed to 
different concentrations of H2O2 regulate hypertrophy and apoptosis by activating 
specific proteins including JNK, ERK1/2, p38 and Akt[54]. Moreover, peroxynitrite 
seems to activate all the members of MAPK, JNK, ERK, and p38 in H9C2 
cardiomyocytes [55]. Taken together, MAPK seems to play a crucial role in ROS 
mediated signal transduction in cardiovascular diseases.[56]  
A study indicated an age associated decline in HSP70 response against thermal 
stress in F344 cardiac muscle[57].  Although this study did not statistically compare the 
basal content of HSP 70, aged cardiac muscle revealed higher HSP 70 content than 
younger ones. Additionally, ischemic injury in cardiomyocytes seems to be alleviated by 
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the over expression of HSP 27[58]. Together, these data suggest aging is associated with 
an alteration in HSP expression in the cardiac muscle. 
 
 13
Chapter 3 
 
Aging influences multiple indices of oxidative 
stress in the heart of the Fischer 344/NNia x 
Brown Norway/BiNia rat.  
 
Shinichi Asano 1, Kevin. M. Rice 1, 2, Sunil Kakarla 1, Anjaiah Katta1, Devashish H. 
Desai 2, Ernest M. Walker 3, Paulette Wehner4, and Eric R. Blough 1, 2 
 
1 Department of Biological Sciences, Marshall University 
2 Department of Pharmacology, Physiology, and Toxicology, Joan C. Edwards  School 
of Medicine, Marshall University 
3 Department of Pathology, Joan C. Edwards School of Medicine, Marshall 
 University 
4 Department of Cardiology, Joan C. Edwards School of Medicine, Marshall 
 University 
 
Author for correspondence: 
 Eric Blough, Ph.D. 
 Laboratory of Molecular Physiology 
Suite 311, Science Bldg. 
 Department of Biological Sciences 
 1 John Marshall Drive 
 Marshall University 
 Huntington, WV 25755-1090 
 Email: blough@marshall.edu 
 
Running Title: Indices of oxidative stress in aging cardiac muscle in the rat heart. 
 14
Abstract 
Here we report  the influence of aging on multiple markers of oxidative-
nitrosative stress in the heart of adult (6-month), aged (30-month) and very aged (36-
month) Fischer 344/NNiaHSd X Brown Norway/BiNia (F344/NXBN) rats.  Compared to 
6 month old rat hearts, indices of oxidative (superoxide anion (–O2·), 4-hyrdoxy-2-
nonenal (4-HNE)) and nitrosative (protein nitrotyrosylation) stress were 34.1 ± 28.1%,  
186 ± 28.1% and 94 ± 5.8% higher, respectively, in 36-month hearts and these findings 
were highly correlated with increases in left ventricular wall thickness (r>0.669; r>0.710 
and p<0.01, respectively).  Regression analysis showed that increases in cardiac 
oxidative-nitrosative stress  with aging were significantly correlated with changes in the 
expression and/or regulation of proteins involved in transcriptional (NF-κB) activities, 
signaling (mitogen activated protein kinases along with Src), apoptotic ( Bcl-2, Traf-2), 
and cellular stress (HSPs).  These results suggest that the aging F344/NXBN heart may 
be highly suited for unraveling the molecular events that lead to age-associated 
alterations in cardiac oxidative stress.  (157 words) 
 
Key words: aging; heart; oxidative-nitrosative stress; cell signaling 
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Introduction  
 Aging is thought to be the major risk factor for the development of cardiovascular 
disease [59]and is associated with alterations in cardiac morphology, signaling, and 
contractile function [60, 61].  Even in the absence of disease, aging in the heart is 
characterized by cardiomyocyte loss, left ventricular hypertrophy, changes in ventricular 
volume, decreases in fractional shortening and reduced cardiac output [36, 62, 63]. 
Although there is no clear consensus on what causes aging or age-related changes in 
cardiac morphology and function, age-associated  increases in oxidative-nitrosative stress 
have been posited as being involved [64]. In addition to their potential role in aging, the 
study of oxidative-nitrosative stress may be important as they seem to play a role in 
cardiac injury, cell death, dysrhythmia and in chronic cardiovascular diseases [18]. It is 
thought that oxidative-nitrosative stress exert their influence, in large part, by causing the 
gradual accumulation of free radical damage to biomolecules [7].  Recent reports have 
supported this hypothesis with data suggesting that aging is associated with alterations in 
the oxidative/nitrosative stress biomarkers H2O2, 3-nitrotyrosine (3-NT), N- -methyl-
lysine, malondialaldehyde, and advanced glycation end products [65, 66]. The effects of 
pharmacological treatments and exercise on oxidative stress are under investigation [67]. 
However, the relation between biomarkers of oxidative-nitrosative stress and alterations 
in tissue structure and function with aging has not been fully examined [68].  
 In an attempt to gain greater physiological insight into effects of oxidative stress, 
the possible effects of oxidative-nitrosative stress on the content and phosphorylation 
status of various cellular proteins is recently being examined.  We and others have 
demonstrated that aging in the Fischer 344/NNiaHSd X Brown Norway/BiNia 
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(F344/NXBN) rat model is characterized by changes in cardiovascular morphology and 
function along with increases in vascular reactive oxygen species (ROS) [36, 69, 70].  
Specifically, recent studies suggest that vascular aging in the F344/NXBN is associated 
with an increase in superoxide anion (–O2·), which is highly correlated with changes in 
aortic morphology, total protein nitration and changes in the expression and/or regulation 
of proteins involved in metabolic (AMPK-α), signaling (mitogen activated protein 
kinases along with c-Src), apoptotic (Bax, Bcl-2, Traf-2), and transcriptional (NF-κB) 
activities [70].  A better understanding of possible relationships between oxidative-
nitrosative stress and the aging F344/NXBN heart may help identify common markers of 
oxidative-nitrosative stress between different tissue and muscle types (cardiac versus 
smooth) in the aging cardiovascular system.  
The purpose of this study was to determine how aging affects multiple, previously 
identified markers of oxidative-nitrosative stress in the rat heart.  We hypothesized that 
aging would be associated with increases in the cardiac content or basal phosphorylation 
of oxidative-nitrosative stress markers.  Similar to our previous study examining the 
aging vasculature, the analyses of oxidative-nitrosative stress markers was performed in 
hearts from young (6 mo), aged (30 mo), and very aged (36 mo) F344/NXBN rats.  Our 
data suggest that aging in the F344/NXBN heart is associated with increases in oxidative-
nitrosative stress, and this alteration is strongly correlated with alterations in cardiac 
morphology and oxidative-nitrosative stress indices.   
 17
Results 
  
Left ventricular wall thickness along with markers of ROS and nitrosative 
stress are increased with aging 
As previously reported, body mass increased with age, while systolic blood pressure was 
not significantly altered [70]. Phosphotungstic Acid-hematoxylin, Malloy’s (PTAH) 
staining of cross sections of cardiac tissues demonstrated evidence of age associated 
pathology, including increased fibrosis and sarcolemmal ulceration (Fig. 1).  Compared 
to the 6 month old animals, left ventricular wall thickness was 59.0 ± 12.7% and 26.3 ± 
13.8% higher in the 30- and 36-months, respectively (P<0.01).  Ethidium fluorescence 
was seen throughout the cardiac cross section (Fig. 2, A).  Quantification of (–O2·) as 
determined by oxidation of hydroethidine (HE) to ethidium bromide (Et) and the 
quantification of Et fluorescence by semiquantitative analysis was 54.2 ± 20.4% and 34.1 
± 28.1% higher in 30- and 36-month cardiac preparations compared to the levels 
determined in 6-month hearts (Fig. 2, B)  (P<0.01). In order to further examine how 
aging may influences ROS production we also examined protein isolates for the presence 
of proteins modified by the lipid peroxidation metabolite 4-hydroxy-2-noneanl (4-
HNE)[71, 72].  Compared to hearts obtained from 6- month animals, 4-HNE levels as 
determined by immunoblotting were 79 .2 ± 4.4% and 94.0 ± 5.8% higher in the 30- and 
36-month heart, respectively (Fig. 3) (P<0.01). 
 Superoxide has been shown to react with nitric oxide to form reactive nitrogen 
species, specifically, peroxynitrite is able to modify proteins by interacting with tyrosine 
residues to form 3-nitrotyrosine [73]. Compared to hearts obtained from 6-month 
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animals, tyrosine nitration, a marker of nitrosative stress,  was 152.2 ± 4.2% and 168.6 ± 
5.2% higher in the 30- and 36-month heart, respectively (P<0.01) (Fig. 4, Table 1).  To 
examine whether these increases in tyrosine nitration were associated with the cardiac 
myocyte, immunohistochemical analysis was performed. Consistent with our 
immunoblotting experiments, with aging we observed an increase in the amount of 
immunoreactive nitro-Tyrosine signal throughout the myocardium of the aging heart that 
appeared to be localized primary within the myocyte (Fig. 4 B-D). Taken together these 
data suggest that increased nitrosative stress may participate in age-related cardiac 
protein modification.   
 
Phosphorylation of the metabolic sensor protein AMPK-α is unaltered with 
aging 
AMPK is a metabolite-sensing protein that senses nutritional and environmental stresses 
and acts as a metabolic master switch [74]. To determine whether aging influenced the 
regulation of AMPK-α in the heart, gel electrophoresis and immunoblot analysis using 
antibodies that recognize both the unphosphorylated and phosphorylated form of AMPK-
α was performed. Compared to hearts obtained from 6- month animals, AMPK-α content 
was unchanged with aging (Fig. 5, Table 1).  Given that AMPK-α is activated by 
phosphorylation, it was important to establish if aging in the heart was characterized by 
changes in the basal phosphorylation level of the threonine 172 residue, a necessary and 
sufficient step for AMPK-α activation and thus an established marker for AMPK-α 
activity. Compared to the 6-month heart, the basal phosphorylation of AMPK-α (Thr 
172) showed no significant change in the 30- or 36-month hearts (Fig. 5, Table 1).     
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The cardiac content and basal phosphorylation of the signaling molecules Src, 
p44-p42 (ERK 1/2)-, p38- and JNK-MAPK are altered with aging 
The Src and MAPK proteins play a key role in propagating external stimuli into the 
cytoplasm and nucleus [75]. Compared to hearts obtained from 6-month animals, JNK-1 
and JNK-3 content was 19.1 ± 9.1%, and 14.7 ± 4.4% higher in the 30-month heart, while 
JNK-2 levels were not different. In the 36-month heart, the JNK-1, JNK-2, and JNK-3 
content was 37.9 ± 6.7%,  30.6 ± 7.0%, and 24.4 ± 2.9% higher, respectively (P<0.01) 
(Fig. 5, Table 1). Compared to hearts obtained from 6-month animals, p38α content was 
higher in both the 30- (54.3 ± 7.3%) and 36-month (42.0 ± 8.9%) heart (P<0.01) (Fig. 5, 
Table 1).  The amount of p44 (ERK1) and p42 (ERK2) was unchanged with aging (Fig. 
5, Table 1).  Compared to 6-month heart, the basal phosphorylation of JNK-1 and JNK-3 
(Thr 183/Tyr 185)-MAPK was 72.1 ± 15.8% and 25.7 ± 8.6% higher in the 30-month 
heart and 47.0 ± 14.5% and 24.5 ± 10.0% higher in the 36-month heart, respectively, 
(P<0.01) (Fig. 6, Table 1). Similarly, the basal phosphorylation of JNK-2 (Thr 183/Tyr 
185) MAPK was 57.0 ± 9.4% and 31.7 ± 11.5% lower in the 30- and 36-month heart 
respectively (P<0.01) (Fig. 6, Table 1). The phosphorylation of p38α (Thr180/ Tyr182) 
was 32.2 ± 7.3% higher in the 30-month hearts and 17.5 ± 4.6% lower in the 36-month 
heart, as compared to the hearts obtained from the 6-month animals (P<0.01) (Fig. 6, 
Table 1). Compared to 6-month heart, the basal phosphorylation of p44 (ERK1) and p42 
(ERK2) (Thr 202/Tyr 204)-MAPK was 108.5 ± 23.5% and 98.7 ± 9.0% higher in the 30-
month heart and 49.1 ± 26.5% and 46.8 ± 7.8% higher in the 36-month heart, 
respectively, (P<0.01) (Fig. 6, Table 1).  Conversely, with aging the amount of Src was 
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17.9 ± 6.2 and 20.2 ± 7.8% lower in the 30- and 36-month heart compared to the 6-month 
heart, respectively (P<0.01) (Fig. 6, Table 1).  The phosphorylation of the active form of 
Src (Tyr 527) was 44.5 ± 12.8% higher in the 30- month heart, compared to the 6-month 
heart (P<0.01) (Fig. 6, Table 1).  However in the 36-month heart the phosphorylation of 
Src (Tyr 527) failed to demonstrate a significant change compared to the 6-month heart 
(Fig.6, Table 1).   
 
Aging altered the cardiac content of the apoptotic regulators Bax, Bcl-2, and 
Traf-2 
Bax, Bcl-2, and Traf-2 are key regulators of apoptosis [76]. With aging, Bax showed no 
significant change at 30-month; however Bax expression was higher in the 36-month 
heart 21.9 ± 7.4% compared to the 6-month age group. Similarly, Bcl-2 content was 97.6 
± 9.8% and 27.5 ± 8.4% (P<0.01) higher in the 30- and 36-month age groups, 
respectively (Fig. 7, Table 1).  On the other hand, Traf-2 was 13.6 ± 6.1% and 7.8 ± 6.8% 
lower in the 30- and 36-month aged heart, respectively (P<0.01) (Fig. 7, Table 1).   
 
  
Aging increases cardiac HSP27 and HSP70 
Exposure to cellular stress is thought to increase the cellular content of the heat shock 
proteins (HSPs) [77] Compared to hearts obtained from 6-month animals, HSP27 content 
was 76.6 ± 14.0% and 82.5 ± 17.4% higher in the 30- and 36-month hearts, respectively 
(P<0.01) (Fig. 7, Table 1).  Similarly, the content of HSP70 in the heart was 47.5 ± 
10.4% and 90.2 ± 7.4% higher in the 30- and 36-month hearts (P<0.01) (Fig. 7, Table 1). 
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Aging alters the expression of the transcription protein NF-κB   
NF-κB is a transcription factor that has been implicated in the control of inflammatory 
responses, cellular growth, and apoptosis [78].  Compared to the hearts obtained from 6-
month animals, NF-κB p65 content was 96.1 ± 16.7% higher and 118.0 ± 8.5% higher in 
the 30- and 36-month heart, respectively (P<0.01). Similarly, NF-κB p50 content was 
66.2 ± 7.5% and 55.7 ± 6.2% higher in the 30- and 36-month heart, respectively (P<0.01) 
(Fig. 7, Table 1). Conversely, with advanced aging the phosphorylated levels of NF-κB 
p65 in the 30-month and 36-month heart were unchanged compared to the 6-month levels 
(Fig. 7, Table 1).   
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Discussion 
There is emerging evidence suggesting that age-related declines in cardiac 
function may be associated with age-associated increases in oxidative-nitrosative stress 
[79]. Presently, it is unclear how these seemingly disparate phenomena are connected. 
Indeed, a causal role of oxidative-nitrosative in the age-dependent decline of cardiac 
dysfunction can only be defined if biological targets of these species are identified and 
the physiological impact of biomolecular modification is characterized. To this end, we 
attempted to investigate the effects of cardiac aging on the regulation of previously 
identified markers of oxidative-nitrosative stress.  We demonstrate that aging in the 
F344/NXBN heart is strongly correlated with, and characterized by elevations in cardiac 
markers of oxdiatvie- nitrosative stress. The increase in these markers of are in turn 
significantly correlated with age-associated increases in ventricular thickness along with 
changes in the expression and /or regulation of proteins involved in intracellular signaling 
(MAPKs along with c-Src), apoptotic (Bax, Bcl-2, Traf-2), heat shock (HSP 27, HSP70) 
and transcriptional (NF-κB) activities. Although not capable of proving cause and effect, 
these data, taken together, suggest that age-associated changes in oxidative-nitrosative 
stress are related to changes in cardiac morphology and multiple signaling pathways 
which influence cell function.    
 Similar to previous reports, utilizing the F344/NXBN[62] and Fischer rat models 
[80] we show an age-related increase in left ventricular thickness. Further, we observed 
an increase in Et fluorescence and 4HNE levels with aging in the F344/NXBN heart 
suggesting increased (–O2·) levels. These findings are consistent with earlier data which 
have suggested that aging is associated with increases in cardiac ROS [81, 82].Using 
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statistical analysis we demonstrate a high correlation between age-associated increases in 
ventricular wall thickness and elevations in ventricular (–O2·) levels as determined by HE 
staining (Fig. 2).  This possibility is supported by recent reports suggesting a link 
between increases in intracellular ROS and cardiomycyte hypertrophy[83] [53, 84, 85]. 
The possible source of increased ROS in the aging myocardium are not fully elucidated 
but could include xanthine and NAD(P)H oxidoreductases, cyclooxygenase, activated 
neutrophils and mitochondrial dysfunction among many others [86-88]. Of these, 
alterations in mitochondrial function may be particularly attractive, Indeed, it is widely 
accepted that aging impairs mitochondria function and that this impairment is often 
associated with increased formation of ROS [89]. How increased age may cause 
alterations in mitochondria function and structure or the accumulation of dysfunctional 
mitochondria is not well understood.  With respect to the latter possibility, Terman and 
colleagues have suggested that age-related increases in the number of lipofuscin-loaded 
lysosomes may cause decreased mitochondrial turnover and favor the accumulation of 
damaged mitochondria [90-92]. Together, these data suggest that the increased (–O2·) in 
the ventricular wall of aged F344/NXBN rats may contribute to age-associated 
ventricular wall thickening and accumulation of lipofuscin.  Whether age-related 
alterations in mitochondrial function or some other mechanism is responsible for the 
increased oxidative stress we see in the aging F344/NXBN heart is currently being 
investigated. 
 Similar to ROS, the excessive production of nitric oxide (NO) by nitric oxide 
synthases which can lead to the generation of the powerful oxidant peroxynitrite have 
also been implicated in the pathogenesis of cardiovascular dysfunction [93]. 
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Peroxynitrite, in turn, is thought to cause the protein nitration and the quantification of 
this latter process is a well established marker for reactive nitrogen species  production 
[94]. In the present study, our data showing an increase in protein tyrosine nitrosylation 
are consistent with the notion that aging increases peroxynitrite formation (Figure 4). 
Although the physiological effects of protein nitration are not entirely elucidated, 
previous studies have suggested that nitration can alter protein function and 
conformation, impose steric restrictions, and also inhibit tyrosine phosphorylation [95]. 
Similar findings of increased protein nitration have recently been reported in the aging 
F344/NXBN heart [96]  In this study, Kanski and co-workers using one- and two-
dimensional western blotting coupled with nanoelectrospray ionization-tandem mass 
spectrometry identified a number of proteins that may have suffered protein nitration as a 
consequence of biological aging.  In particular, these researchers demonstreated that 
aging may be associated with the nitration of cytochrome C oxidase (~19 kDa), ATPase 
(~28 kDa), GAPDH (~38 kDa), and NADH ubiquinone oxireductase (~75 kDa).  
Qualitative inspection of our Nitro-Tryrosine immunoblotting experiments suggests the 
presence of immunoreactive bands around these molecular weights (Figure 3).  Whether 
the proteins identified in our analysis are the same as those identified by Kanski and 
colleagues is unknown and will necessitate further experimentation.   
 Increased nitrosative stress may also be involved in regulating the 
phosphorylation state of MAPK proteins.  For example, recent data has suggested that 
peroxynitrite may induce ERK1/2, p38, and JNK phosphorylation 
in cultured H9C2 cardiomyocytes[55]. Using protein isolates from aged cardiac samples, 
our data suggests that a similar relationship (r > 0.6) may exist in the intact aging rat heart 
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(Table 2). Whether alterations in MAPK phosphorylation are due to nitrosative stress or 
some other mechanism will require further experimentation. In addition to its effects on 
protein structure and function, excessive nitrosative stress may cause severe DNA 
damage, activation of poly(ADP-ribose) polymerase(PARP) and the depletion of NAD+ 
and ATP[97]. Allowed to proceed unchecked, the end result of these latter processes is 
often cell death[98]. Our findings of a correlation between level of nitrotyrosine 
modification with aging and the cardiac content of the apoptotic regulators, Bax and Bcl-
2 are consistent with this possibility.  
 The mechanism(s) by which oxidative-nitrosative stress may exert hypertrophic 
effects on cardiomyocytes is not fully understood.  Furthermore, how aging may affect 
cardiac intracellular signaling processes has not been clearly defined.  Thus far, research 
examining these questions has been performed, in large part, utilizing cell culture models.  
Using intact hearts, we demonstrate that alterations in the regulation of JNK-MAPK, 
ERK1/2-MAPK, HSP27, nitrotyrosine, 4-HNE, and NF-ĸB p50 were strongly correlated 
(r > 0.70) with aging along with increases in F344/N X BN left ventricular thickness 
(Tables 1, 2).  Taken together, these data suggest that these molecules may be particularly 
involved in mediating the age-associated remodeling of the F344/NXBN heart.  To our 
knowledge these findings have not been reported before. Nonetheless, these results are in 
agreement with previous reports suggesting that these proteins may play a role in cardiac 
remodeling [99-104]. Of particular interest are our findings that the phosphorylation 
(activation) of the JNK- and ERK-MAPK proteins appears to be regulated differently 
with aging. For example, whereas the JNK 1, JNK 2, and ERK-2 (p42) isoforms are 
strongly correlated with aging and ventricular hypertrophy, JNK 3 or ERK 1 is not (Table 
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2).  Although the function of the different JNK or ERK1/2 MAPK isoforms is not fully 
understood, recent reports have begun to shed light on this area of research. For example, 
recent studies by Tachibana and colleagues [105] along with Kaiser and associates [106] 
have suggested that JNK1 and JNK2 play a protective role in cardiac myocytes by 
functioning to prevent cardiac inflammation and apoptosis. The cardioprotective effects 
of transforming growth factor-ß1 during ischemia-reperfusion were shown to mediated 
via Erk1/2, ERK 2 is also thought to function in a cardioprotective role [107] whereas 
others have suggested the involvement of ERK 2 in ROS-mediated cell hypertrophy 
[108]. Whether the alterations in JNK 1, JNK 2 and ERK 2 regulation we see with aging 
in the F344/NXBN are related to cardioprotective or hypertrophic processes awaits 
further clarification.   
 The heat shock proteins are thought to be induced by stressful stimuli and have 
been shown to protect cells and organs from cellular insult [109].  In vitro studies have 
demonstrated that HSP 27 acts as a molecular chaperone, as an actin capping-decapping 
protein stabilizing the cytoskeleton, and as a defense mechanism against elevated ROS 
[110].  What role(s) HSP 27 may play in the aging heart has not been fully defined.  With 
aging we show a marked increase in HSP 27 protein levels (Figure 9, Table 1).  Although 
determining the function that HSP 27 may play in the aging F344/NXBN heart is beyond 
the scope of the present investigation, previous studies employing ischemic stimuli, a 
known stimulator of intracellular ROS, have suggested that HSP27 may play a role in 
cardioprotection [111]. We speculate that age-associated increases in HSP 27 may be a 
compensatory mechanism to circumvent the augmented ROS we show with aging in the 
F344/NXBN heart.     
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 It has been hypothesized that ROS may contribute to the biology of aging through 
NF-ĸB mediated regulation of gene expression [112]. In addition, several recent studies 
have revealed a novel relationship between NF-ĸB and JNK-MAPK in which NF-ĸB is 
thought to antagonize JNK activation and act to suppress apoptosis [22, 113]. That data 
of the present investigation are consistent with this notion.  In addition to the possible 
role that NF-ĸB may play in regulating cell death, others have reported that NF-ĸB may 
be involved in mediating cardiac hypertrophy [114]and even as an antioxidant [115, 116]. 
Further studies will be needed to discern what role NF-ĸB may play in the aging heart. 
 In summary, we have found that aging in the F344/NXBN heart is characterized 
by increased levels of oxidative- nitrosative stress and alterations in several signal 
transduction pathways.  Further information on the individual or combined effects of 
these changes may reveal their role in aging cardiac morphology and function.  Indeed, 
there is much remaining to be learned about the signaling cascades involved and the 
points at which ROS exert their effects.  Due to the similarities between the aging 
F344/NXBN and humans [117, 118] our data suggest that the aging F344/NXBN heart 
may be highly suited for unraveling the molecular events that lead to age-associated 
alterations in cardiac ROS.   
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Experimental Procedures 
 
Animals 
All procedures were performed as outlined in the Guide for the Care and Use of 
Laboratory Animals as approved by the Council of the American Physiological Society 
and the Animal Use Review Board of Marshall University.  Adult (6 months), aged (30 
months) and very aged (36 months) male F344/NXBN rats were obtained from the NIA.  
Probability of survival curves generated by the NIA has indicated that rats of these ages 
generally represent humans in their third, sixth and eighth decade of life, respectively[35, 
118, 119]. Data collected from these animals regarding age associated alterations in aortic 
ROS levels have previously been published [70]. 
Rats were barrier housed individually in an AAALAC approved vivarium.  
Housing conditions consisted of a 12H: 12H dark-light cycle and temperature was 
maintained at 22° ± 2°C.  Animals were provided food and water ad libitum.  Rats were 
allowed to recover from shipment for at least two weeks before experimentation began. 
During this time the animals were carefully observed and weighed weekly to ensure none 
exhibited signs of failure to thrive, such as precipitous weight loss, disinterest in the 
environment, or unexpected gait alterations. Systolic blood pressure was determined with 
the animal unanesthetized using a programmed electrosphygmomanometer with 
pneumatic tail cuff (Narco-Biosystems, Houston, TX).  Animals were acclimated to the 
procedure for a minimum of 3 days prior to obtaining blood pressure. 
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Materials 
Antibodies against Bax (N-20) [sc-493], Bcl-2 (C-2) [sc-7382], HSP27 (M-20) 
[sc-1049], HSP70 (K-20) [sc-1060], NF-κB p50 (E-10) [sc-8414] and Traf-2 (C-20) [sc-
876], mouse IgG, goat IgG, and rabbit IgG antibodies were purchased from Santa Cruz 
Biotechnology, Inc. (Santa Cruz, CA).  Antibodies against AMPK-α [#2532], 
p44/42(ERK1/2-MAPK) [#9102], p38-MAPK α [#9218], SAPK/JNK-MAPK [#9252], 
NF-κB p65 [#3034], Non-phospho-Src (Tyr527) [#2107], p-AMPK-α (Thr 172) [#2531], 
p-p44/42 (Thr 202/ Try 204) [#9106], p-p38 (Thr 180/ Try 182) [#9216], p-SAPK/JNK 
(Thr 183/Tyr 185) [#9251], p-NF-κB p65 (Ser536) [#3031], p-Src (Tyr527) [#2105], 
Nitro-Tyrosine [#9691], Biotinylated protein ladder, mouse and rabbit IgG antibodies 
were purchased from Cell Signaling Technology (Beverly, MA) while anti-4-HNE 
(MHN-020P) was from (JaICA, Shizuoka, Japan). The dihydroethidium (hydroethidine) 
[HE] was obtained from Molecular Probes (Eugene, OR).  Precast 10% SDS-PAGE gels 
were procured from Cambrex Biosciences (Baltimore, MD), and enhanced 
chemiluminescence (ECL) western blot detection reagent was acquired from Amersham 
Biosciences (Piscataway, NJ).  Restore western blot stripping buffer was obtained from 
Pierce (Rockford, IL) and 3T3 cell lysates were from Santa Cruz Biotechnology (Santa 
Cruz, CA).  All other chemicals were purchased from Sigma (St. Louis, MO).  
 
Heart Collection 
 Rats were anesthetized with a ketamine-xylazine (4:1) cocktail (50 mg/kg IP) and 
supplemented as necessary for reflexive response. After midline laparotomy, the heart 
was removed and placed in Krebs-Ringer bicarbonate buffer (KRB) containing; 118 mM 
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NaCl, 4.7 mM KC1, 2.5 mM CaCl2, 1.2 mM KH2PO4, 1.2 mM MgSO4, 24.2 mM 
NaHCO3, and 10mM α-D-glucose,  (pH 7.4) equilibrated with 5% CO2 / 95% O2 and 
maintained at 37°C.  Isolated hearts were quickly massaged to remove any blood from 
the ventricles, cleaned of connective tissue, weighed, and immediately snap frozen in 
liquid nitrogen.  
 
Histology and Oxidative Fluorescent Microscopy  
 Heart specimens were serially sectioned (8 μm) using an IEC Minotome cryostat 
and collected on poly-lysine coated slides.  After fixing in acetone, (-20°C for 2 min) 
sections were stained with hematoxylin and eosin, mounted and cover slipped.  
Morphometric evaluation was performed with the use of a computerized imaging analysis 
system (Olympus MicroSuite™ Basic).  Ventricular and septal wall thickness in μm was 
calculated from the average of eight different points of cross section. Phosphotungstic 
Acid-hematoxylin, Malloy’s (PTAH) staining of serially sectioned cardiac tissue was 
performed according to the manufactures guidelines (poly Scientific R & D Corp., Bay 
Shore, NY). 
 Hydroethidine (HE), an oxidative fluorescent dye, was used to visualize 
superoxide production in situ [120, 121].  HE freely permeates the cells and in the 
presence of (–O2·) is oxidized to ethidium bromide (Et), where it is trapped by 
intercalating with the DNA [122].  Because Et is impermeable to cell membranes, 
extracellular (–O2·) would not be expected to significantly contribute to the observed 
cellular fluorescence. Neither hydroxyl radical, ·NO, peroxynitrite, H2O2, hypochlorite, 
nor singlet O2 significantly oxidizes HE, as such, an increase in Et fluorescence is thought 
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to specifically indicate (–O2·) generation within the fluorescing cell.  Heart sections were 
stained with HE and visualized under fluorescence as described previously [70].  The 
intensity of fluorescent Et–stained nuclei was calculated by digitizing images and then 
determining the average pixel intensity of six randomly positioned regions (1000 µm2) 
per arterial cross section.  Eight images per vessel were analyzed with ≥ 500 nuclei per 
vessel examined.   
 
Immunohistochemistry 
 Immunostaining for Nitro-Tyrosine was visualized by immunofluorescence as 
outlined by the antibody manufacturer.  Briefly, sections were washed three times with 
phosphate buffered saline (PBS) containing 0.5% Tween 20 (PBS-T), pH 7.5.  After 
incubation for 30 min in a blocking solution (5% BSA) sections were incubated with 
specific antisera diluted in PSB-T (antibody dilution of 1:100) for 1 hr at 24° C in a 
humidified chamber.  After washing three times in PBS, sections were incubated with 
FITC anti-rabbit IgG (1:200) for 30 min at 24° C in a humidified chamber.  DAPI was 
also included in the secondary antibody solution at a concentration of 1.5 μg /ml in order 
to visualize cell nuclei.  After a final PBS wash and mounting specimens were visualized 
by epifluorescence using an Olympus fluorescence microscope (Melville, NY) fitted with 
a 40X objective.  Images were recorded digitally using a CCD camera and analyzed using 
Olympus MicroSuite™ Basic from Olympus America (Melville, NY).   
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Immunoblot Analysis 
Tissues were pulverized in liquid nitrogen using a mortar and pestle until a fine 
powder was obtained and washed three times with ice cold PBS as described previously 
[123].  Samples were then suspended on ice in 100 μl of TPER  (2 mL/1g tissue weight) 
(Pierce, Rockford, IL) supplemented with 100 mM NaF, 1 mM Na3VO4, 2mM PMSF, 1 
μg/ml aprotinin, 1 μg/ml leupeptin, and 1 μg/ml pepsatin.  After lysis, homogenates were 
centrifuged 10 min at 13,000 g and the supernatant collected.   
Protein concentrations of homogenates were determined in triplicate via the 
Bradford method (Pierce) using bovine serum albumin as a standard.  Samples were 
diluted to a concentration of 3 mg/ml in SDS-loading buffer and boiled for 5 minutes.  
Sixty μg of total protein for each sample was separated on a 10% SDS-PAGE gel.  
Transfer of protein onto nitrocellulose membranes was performed using standard 
conditions.  To verify transfer of proteins and equal loading of lanes the membranes were 
stained with Ponceau S.  Semiquantitiative immunodetection of specific proteins was 
performed using established methods as described previously [70].  A total of three SDS-
PAGE gels were run for each experimental set to evaluate changes in dependent variable 
tissue content and basal phosphorylation where applicable.  Immunoblots were stripped 
with Restore western blot stripping buffer as described by the manufacturer to obtain 
direct comparisons between expression and phosphorylation levels of different signaling 
molecules.  After verifying the absence of residual HRP activity by reacting the 
membrane with the ECL reagent, membranes were washed and reprobed.  Randomization 
of antibody incubation was utilized to minimize potential experimental error associated 
with membrane stripping. 
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Data Analysis 
Results are presented as mean ± SEM.  Data were analyzed by using the 
SigmaStat 3.0 statistical program.  A one-way analysis of variance (ANOVA) was 
performed for overall comparisons with the Student-Newman-Keuls post hoc test used to 
determine differences between groups.  Regression analysis of the dependent variables 
was performed across age groups using values from four individual hearts from each 
group.  Significance of correlation was analyzed by one-way ANOVA. The level of 
significance accepted a priori was ≤ 0.01.  
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Chapter 4 
 
Conclusions and Future Directions 
Conclusions 
1. Aging significantly affects the presence of ROS in the F344/NXBN heart. The 
increased ROS are significantly correlated with age-associated increases in 
ventricular wall thickness.  
 
2. Aging significantly alters the expression and phosphorylation of proteins 
associated with cell signaling, apoptotic, heat shock and transcription activities in 
the F344/NXBN heart.  
 
3. Age-associated increases in ROS are strongly correlated with multiple previously 
identified markers of oxidative stress (MAPK, Src, Bax, Bcl-2, NF-κB, and HSP) 
in the rat heart. 
 
 35
Future Directions 
Future directions for research based on this study should focus on the mechanism 
of ROS mediated signal transduction in the aged cardiac muscle as well as the effect of 
pharmacological and / or exercise on ROS levels and signaling. Indeed, the importance of 
ROS on the aging process has been emphasized for a half century. Today, this aging issue 
seems to become much more serious concern than ever before because a huge baby boom 
population will be categorized as aged population. A better understanding of the 
mechanisms involved in ROS mediated cell signal transduction may support 
implementing an anti-aging approach. Currently, aging and mitochondria dysfunction are 
under investigation. It is conceivable that this potential ROS generating organelle may 
play a crucial role in the process of aging. Future studies designed to determine how 
aging may affect mitochondrial structure, function and ROS generation may be 
invaluable to furthering our understanding of the potential sources of age-associated ROS 
generation.  
 Additionally, studies related to ROS scavengers such as anti-oxidants may 
provide a treatment for accumulation or overproduction of ROS, in much the same way 
that drugs produced to treat and cure one illness are found to be quite effective in treating 
one another. Studies designed to investigate the effects of anti-oxidants on cardiac ROS 
with aging may elucidate new treatments that could be recommended for the prevention 
of age-associated cardiovascular disease. Future research will no doubt add to our 
understanding and if successful may be useful for decreasing the incidence of 
cardiovascular dysfunction in the aging population.  
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Appendix 
Appendix A 
Table 1.  Tissue concentration and basal levels of protein phosphorylation in heart 
excised from young adult (6 month), aged (30 month), and very aged (36 month) Fischer 
344/NNiaHSd X Brown Norway/BiNia F1 hybrid rats.  Data was obtained from 
immunoblotting analysis using antibodies that recognize the unphosphorylated or 
phosphorylated forms of the proteins.  Data are presented as percentages of the young 
adult value ± SE.  The results reflect the analysis of combined protein comparisons of 
four individual hearts from each age group.  An asterisk (*) designates significant 
differences from 6-month age group (p < 0.001). 
 
Table 2. Regression analysis of the relationship between expression levels of specific 
proteins and age, HE staining intensity, protein nitro-tyrosine levels, 4-HNE levels and 
left ventricular thickness of hearts obtained young adult (6 month), aged (30 month), and 
very aged (36 month) Fischer 344/NNiaHSd X Brown Norway/BiNia F1 hybrid rats.  
The results reflect the analysis of combined proteins and thickness comparisons of four 
individual hearts from each age group.  An asterisk (*) indicates low correlation between 
parameters (p < 0.05), (†) indicates moderate correlation (p < 0.05), (††) indicates high 
correlation (p < 0.05), (†††) indicates very high correlation (p < 0.05).  N.T. (not tested). 
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Table 1 
 6 Month 30 Month 36 Month 
Metabolic    
    
AMPK-α 100.0 ±  1.5 +   101.8 ±   2.4 +    101.7 ±   3.4 
p-AMPK-α (Thr 172) 100.0 ±  3.5 -      9.0   ±   5.8 +    110.0 ±   4.5 
    
Signaling    
    
JNK 1 100.0 ±   3.7 +   119.1 ±   5.4* +   137.9 ±   3.0* 
JNK 2 100.0 ±  3.7 +   108.8 ±   2.4 +   130.6 ±   3.3* 
JNK 3 100.0 ±   2.1 +   114.7 ±   2.2* +   124.4 ±   0.8* 
p-JNK 1 (Thr 183/ Tyr 185) 100.0 ±   6.1 +   172.1 ±   9.7* +   147.0 ±   8.4* 
p-JNK 2 (Thr 183/ Tyr 185) 100.0 ±   6.0 -      57.0 ±   3.4* -      31.7 ±   5.5* 
p-JNK 3 (Thr 183/ Tyr 185) 100.0 ±   4.4 +   125.7 ±   4.2* +   124.5 ±   5.6* 
p38 100.0 ±   2.5 +   154.3 ±   4.1* +   142.0 ±   5.7* 
p-p38 (Thr 180/Tyr 182) 100.0 ±   2.5 +   132.2 ±   4.8* -      17.5 ±   2.1* 
p44 100.0 ±   3.1 +   105.6 ±   2.2  +   102.0 ±   5.4 
p42 100.0 ±   1.2 +   103.2 ±   1.4  +   101.4 ±   3.1 
p-p44 (Thr 202/Tyr 204)  100.0 ±  19.8 +   208.5 ±   3.7* +   149.1 ±   6.7* 
p-p42 (Thr 202/Tyr 204) 100.0 ±   2.0 +   198.7 ±   6.9* +   146.8 ±   5.7* 
Src 100.0 ±   3.3 -      17.9 ±   3.0* -     20.2 ±   4.6* 
p-Src (Tyr 527) 100.0 ±   9.1 +   144.5 ±   3.7* -      7.47 ±   8.7 
    
Apoptotic Regulators    
    
Bax 100.0 ±   4.2 +   104.6 ±   6.4 +     121.9 ±   3.2* 
Bcl-2 100.0 ±   5.0 +   197.6 ±   4.8* +     127.5 ±   3.4* 
Traf-2 100.0 ±  5.5 -      13.6 ±   0.6 -          7.8 ±   1.3 
    
Heat Shock Proteins    
    
HSP 27 100.0 ±   8.7 +   176.6 ±   5.3* +      182.5 ±  8.7* 
HSP 70 100.0 ±   4.3 +   147.5 ±   6.1* +      190.2 ±  3.1* 
    
Protein Modification    
    
Nitro-Tyrosine 100.0 ±   1.9 +   252.2 ±   2.3* +      268.6 ±  3.3* 
4-HNE 100.0 ±   4.3 +   179.3 ±   4.4* +      194.0 ±  5.8* 
    
Transcription Factors    
    
NF-κB p50 100.0 ±   3.0 +   166.2 ±   4.5* +      155.7 ±  3.3* 
NF-κB p65 100.0 ±   7.8 +   196.1 ± 13.8* +      218.0 ±  5.7* 
p-NF-κB p65 100.0 ±   2.9 -       6.6 ±   1.7 +      107.7 ±  5.3 
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Table 2 
 Age HE  4-HNE Nitro-
Tyrosine 
Left Ventricular 
Thickness 
Independent 
Variable 
     
      
Age N.T. 0.652† 0.985††† 0.993††† 0.682† 
HE 0.652† N.T. 0.661† 0.663† 0.669† 
Nitro-Tyrosine 0.993††† 0.663† 0.981††† N.T. 0.735†† 
4-HNE 0.985††† 0.661† N.T. 0.981††† 0.710†† 
Left Ventricular 
Thickness 
0.682† 0.669† 0.710†† 0.735†† N.T. 
      
Metabolic      
      
AMPK-α 0.267 0.209 0.240 0.291 0.437* 
p-AMPK-α (Thr 172) 0.183 0.181 0.125 0.143 0.240 
      
Signaling      
      
JNK 1 0.839†† 0.426* 0.798†† 0.801†† 0.367* 
JNK 2 0.762†† 0.376* 0.732†† 0.691† 0.223 
JNK 3 0.913††† 0.515† 0.871†† 0.881†† 0.487* 
p-JNK 1 (Thr 183/ 
Tyr 185) 
0.763†† 0.623† 0.766†† 0.813†† 0.742†† 
p-JNK 2 (Thr 183/ 
Tyr 185) 
0.724†† 0.613† 0.746†† 0.765†† 0.851†† 
p-JNK 3 (Thr 183/ 
Tyr 185) 
0.774†† 0.448* 0.764†† 0.806†† 0.590† 
p38 0.872†† 0.673† 0.869†† 0.903††† 0.811†† 
p-p38 (Thr 180/Tyr 
182) 
0.010 0.208 0.005 0.080 0.560† 
p44 0.195 0.263 0.230 0.195 0.255 
p42 0.294 0.342* 0.311* 0.280 0.361* 
p-p44 (Thr 202/Tyr 
204) 
0.613† 0.586† 0.622† 0.622† 0.810†† 
p-p42 (Thr 202/Tyr 
204) 
0.708†† 0.675† 0.719†† 0.762†† 0.876†† 
Src 0.798†† 0.550† 0.786†† 0.813†† 0.655† 
p-Src (Tyr 527) 0.082 0.255 0.098 0.178 0.546† 
      
Apoptotic 
Regulators 
     
      
Bax 0.597† 0.254 0.574† 0.561† 0.207 
Bcl-2 0.578† 0.579† 0.589† 0.649† 0.884†† 
Traf-2 0.467* 0.535† 0.473* 0.481* 0.624† 
      
Heat Shock Proteins      
      
HSP 27 0.927††† 0.564† 0.917††† 0.928††† 0.727†† 
HSP 70 0.928††† 0.526† 0.906††† 0.895†† 0.438* 
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Transcription 
Factors 
     
      
NF-κB p50 0.904††† 0.669† 0.902††† 0.931††† 0.809†† 
NF-κB p65 0.950††† 0.687† 0.954††† 0.942††† 0.684† 
p-NF-κB p65 0.207 0.118 0.246 0.159 0.084 
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Figure 1.  Aging alters cardiac tissue morphology. PTAH staining of 6- and 36 – 
month hearts demonstrating age associated change.  A and C. Denote 6- month heart 
sections displaying typical cardiac striation pattern.  Bar indicates 50 or 20 µm.  B and D. 
Denote 36- month heart sections displaying atypical cardiac striation pattern with fibrous 
tissue infiltration.  Bar indicates 50 and 20 µm. n = 4 hearts per age group. 
 
Figure 2.  Aging increases cardiac ROS.  A. Detection of vascular superoxide by 
dihydroethidium (hydroethidine) with aging in the heart of 6-, 30- and 36-month 
F344/NXBN.   The increase in superoxide involves all regions within the ventricular 
wall.  Bar indicates 20 µm.  B. Quantification of cardiac ROS as determined by intensity 
of fluorescent Et–stained nuclei.  Results are expressed as percent of the 6 month value.  
An asterisk (*) indicates significant difference from the young adult (6 month) value, p < 
0.01, n = 4 hearts per age group. 
 
Figure 3. Aging increases 4-HNE content in cardiac muscle. 
The quantity of 4-HNE modified proteins was measured from young adult (6 month), 
aged (30 month), and very aged (36 month) rat hearts. Results are expressed as percent of 
the 6 month value. An asterisk (*) indicates significant difference from the young adult (6 
month) value, p < 0.01 or less, n = 4 observations per group.  
 
Figure 4.  Increasing age in the heart is associated with increases the nitration of 
tyrosine residues.  Proteins isolated from the heart of young adult (6 month), aged (30 
month), and very aged (36 month) rats were analyzed by immunoblotting for age-related 
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changes in the extent of protein tyrosine nitration.  A. Results are expressed as percent of 
the 6 month value.  An asterisk (*) indicates significant difference from the young adult 
(6 month) value, p < 0.01 or less, n = 4 observations per group. Immunohistologial 
staining of 6-, 30-, and 36 – month hearts demonstrating age associated change in Nitro-
Tyrosine immunoflorecense.  B - D. Denote 6- , 30-, and 36- month heart sections 
displaying immunoreactivty specific for nitrosylated proteins. 
 
 
Figure 5.  Aging differentially affects the expression and/or regulation of proteins 
involved in AMPK and the concentration of MAPK protein in rat heart.  Hearts 
from young adult (6 month), aged (30 month), and very aged (36 month) rats were 
analyzed by immunoblotting for age-related changes in AMPK and in phosphorylated 
AMPK-α (Thr 172), p44 (ERK1), p42 (ERK 2), p38-α, JNK-1, JNK-2, and JNK-3 
protein content.  Results are expressed as percent of the 6 month value.  An asterisk (*) 
indicates significant difference from the young adult (6 month) value, p < 0.01 or less, n 
= 4 observations per group. 
 
Figure 6. Aging differentially affects the phosphorylation status of the signaling 
proteins in the rat heart. Protein extracts obtained from the hearts of young adult (6 
month), aged (30 month), and very aged (36 month) rats were analyzed by 
immunoblotting for age-related changes in phosphorylated p44 (ERK 1), p42 (ERK 2) 
(Thr 202/ Tyr 204) , p38-α (Thr 180/ Tyr 182), JNK-1 (Thr 183/ Tyr 185), JNK-2 (Thr 
183/ Tyr 185), JNK-3 (Thr 183/ Tyr 185), Src and p-Src (Tyr527) protein content. 
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Results are expressed as percent of the 6 month value.  An asterisk (*) indicates 
significant difference from the young adult (6 month) value, p < 0.01 or less, n = 4 
observations per group.  
 
 
Figure 7.  Aging alters apoptotic, transcriptional and heat shock proteins levels. 
Protein isolates from hearts excised from young adult (6 month), aged (30 month), and 
very aged (36 month) rats were analyzed by immunoblotting for age-related changes in 
Bax, Bcl-2, Traf-2, HSP27, HSP70, NF-κB p65 and NF-κB p50 protein content. Results 
are expressed as percent of the 6 month value.  An asterisk (*) indicates significant 
difference from the young adult (6 month) value, p < 0.01 or greater, n = 4 observations 
per group. 
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Appendix B 
Aging Cytosolic heart 
Film Properties Report for AMPK- α 
Experimenter:  Shinichi Asano 
Muscle / Tissue: Cytosolic cardiac muscle            
Species:  F 344/NNia x Brown Norway/BiNia rat 
Protein concentration:  1.5 µg/ml            Gel type:  10% Tris-HCL SDS_PAGE 
Electrophoresis Voltage:  124V Transfer Voltage:  24V Duration:  45 min 
Primary Antibody: AMPK-α (Cell Signal)  Primary Antibody Dilution:  1/1000 
 Incubation Time:  1hr @ Room temp  Medium:  5% BSA in TBS-T 
Secondary Antibody:  Anti-Rabbit   Secondary Antibody Dilution:1/1000 
 Incubation Time:  1hr@room temp  Medium:  5% milk in TBS-T 
Exposure Time:  15 seconds    Molecular weight:  62 kDa 
Lane 1:  Biotinylated Ladder 16µl 
Lane 2:  Rainbow Marker RPN756 8 µl 
Lane 3:  6month 20 µl 
Lane 4:  6month 20 µl 
Lane 5:  6month 20 µl 
Lane 6:  30month 20 µl 
Lane 7:  30month 20 µl 
Lane 8:  36month 20 µl 
Lane 9:  36month 20 µl 
Lane 10:  36month 20 µl 
Lane 11:  36month 20 µl 
Lane 12:  Positive control 16 µl 
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Aging Cytosolic heart 
Film Properties Report for Phospho-AMPK-α 
Experimenter:  Shinichi Asano 
Muscle / Tissue: Cytosolic cardiac muscle            
Species:  F 344/NNia x Brown Norway/BiNia rat 
Protein concentration:  1.5 µg/ml            Gel type:  10% Tris-HCL SDS_PAGE 
Electrophoresis Voltage:  124V Transfer Voltage:  24V Duration:  45 min 
Primary Antibody: P-AMPK-α (thr172)(Cell Signal)Primary Antibody Dilution:  1/1000 
 Incubation Time:  Overnight @ 4°C  Medium:  5% BSA in TBS-T 
Secondary Antibody:  Anti-Rabbit   Secondary Antibody Dilution:1/1000 
 Incubation Time:  1hr@room temp  Medium:  5% milk in TBS-T 
Exposure Time:  1 minutes    Molecular weight:  62 kDa 
Lane 1:  Biotinylated Ladder 16µl 
Lane 2:  Rainbow Marker RPN756 8 µl 
Lane 3:  6month 20 µl 
Lane 4:  6month 20 µl 
Lane 5:  6month 20 µl 
Lane 6:  30month 20 µl 
Lane 7:  30month 20 µl 
Lane 8:  36month 20 µl 
Lane 9:  36month 20 µl 
Lane 10:  36month 20 µl 
Lane 11:  36month 20 µl 
Lane 12:  Positive control 16 µl 
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Aging Cytosolic heart 
Film Properties Report for SAPK/JNK 
Experimenter:  Shinichi Asano 
Muscle / Tissue: Cytosolic cardiac muscle            
Species:  F 344/NNia x Brown Norway/BiNia rat 
Protein concentration:  1.5 µg/ml            Gel type:  10% Tris-HCL SDS_PAGE 
Electrophoresis Voltage:  124V Transfer Voltage:  24V Duration:  45 min 
Primary Antibody: SAPK/JNK (Cell Signal)  Primary Antibody Dilution:  1/1000 
 Incubation Time:  1hr @ Room temp  Medium:  5% BSA in TBS-T 
Secondary Antibody:  Anti-Rabbit   Secondary Antibody Dilution:1/1000 
 Incubation Time:  1hr@room temp  Medium:  5% milk in TBS-T 
Exposure Time:  15 seconds    Molecular weight:  46, 49, 54 kDa 
Lane 1:  Biotinylated Ladder 16µl 
Lane 2:  Rainbow Marker RPN756 8 µl 
Lane 3:  6month 20 µl 
Lane 4:  6month 20 µl 
Lane 5:  6month 20 µl 
Lane 6:  30month 20 µl 
Lane 7:  30month 20 µl 
Lane 8:  36month 20 µl 
Lane 9:  36month 20 µl 
Lane 10:  36month 20 µl 
Lane 11:  36month 20 µl 
Lane 12:  Positive control 16 µl 
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Aging Cytosolic heart 
Film Properties Report for Phospho-SAPK/JNK 
Experimenter:  Shinichi Asano 
Muscle / Tissue: Cytosolic cardiac muscle            
Species:  F 344/NNia x Brown Norway/BiNia rat 
Protein concentration:  1.5 µg/ml            Gel type:  10% Tris-HCL SDS_PAGE 
Electrophoresis Voltage:  124V Transfer Voltage:  24V Duration:  45 min 
Primary Antibody: P- SAPK/JNK (Cell Signal) Primary Antibody Dilution:  1/1000 
 Incubation Time:  Overnight @ 4°C  Medium:  5% BSA in TBS-T 
Secondary Antibody:  Anti-Rabbit   Secondary Antibody Dilution:1/1000 
 Incubation Time:  1hr@room temp  Medium:  5% milk in TBS-T 
Exposure Time:  1 minutes    Molecular weight:  46,49,54 kDa 
Lane 1:  Biotinylated Ladder 16µl 
Lane 2:  Rainbow Marker RPN756 8 µl 
Lane 3:  6month 20 µl 
Lane 4:  6month 20 µl 
Lane 5:  6month 20 µl 
Lane 6:  30month 20 µl 
Lane 7:  30month 20 µl 
Lane 8:  36month 20 µl 
Lane 9:  36month 20 µl 
Lane 10:  36month 20 µl 
Lane 11:  36month 20 µl 
Lane 12:  Positive control 16 µl 
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Aging Cytosolic heart 
Film Properties Report for P38 MAP Kinase  
Experimenter:  Shinichi Asano 
Muscle / Tissue: Cytosolic cardiac muscle            
Species:  F 344/NNia x Brown Norway/BiNia rat 
Protein concentration:  1.5 µg/ml            Gel type:  10% Tris-HCL SDS_PAGE 
Electrophoresis Voltage:  124V Transfer Voltage:  24V Duration:  45 min 
Primary Antibody: P38 MAP Kinase (Cell Signal) Primary Antibody Dilution:  1/1000 
 Incubation Time:  Overnight @ 4°C  Medium:  5% BSA in TBS-T 
Secondary Antibody:  Anti-Rabbit   Secondary Antibody Dilution:1/1000 
 Incubation Time:  1hr@room temp  Medium:  5% milk in TBS-T 
Exposure Time:  5seconds    Molecular weight:  40 kDa 
Lane 1:  Biotinylated Ladder 16µl 
Lane 2:  Rainbow Marker RPN756 8 µl 
Lane 3:  6month 20 µl 
Lane 4:  6month 20 µl 
Lane 5:  6month 20 µl 
Lane 6:  30month 20 µl 
Lane 7:  30month 20 µl 
Lane 8:  36month 20 µl 
Lane 9:  36month 20 µl 
Lane 10:  36month 20 µl 
Lane 11:  36month 20 µl 
Lane 12:  Positive control 16 µl 
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Aging Cytosolic heart 
Film Properties Report for Phospho-P38(Thr180/Tyr182) 
Experimenter:  Shinichi Asano 
Muscle / Tissue: Cytosolic cardiac muscle            
Species:  F 344/NNia x Brown Norway/BiNia rat 
Protein concentration:  1.5 µg/ml            Gel type:  10% Tris-HCL SDS_PAGE 
Electrophoresis Voltage:  124V Transfer Voltage:  24V Duration:  45 min 
Primary Antibody: P- P38(Thr180/182)(Cell Signal) Primary Antibody Dilution:  1/1000 
 Incubation Time:  Overnight @ 4°C  Medium:  5% BSA in TBS-T 
Secondary Antibody:  Anti-Mouse   Secondary Antibody Dilution:1/1000 
 Incubation Time:  1hr@room temp  Medium:  5% milk in TBS-T 
Exposure Time:  1 minutes    Molecular weight:  38 kDa 
Lane 1:  Biotinylated Ladder 16µl 
Lane 2:  Rainbow Marker RPN756 8 µl 
Lane 3:  6month 20 µl 
Lane 4:  6month 20 µl 
Lane 5:  6month 20 µl 
Lane 6:  30month 20 µl 
Lane 7:  30month 20 µl 
Lane 8:  36month 20 µl 
Lane 9:  36month 20 µl 
Lane 10:  36month 20 µl 
Lane 11:  36month 20 µl 
Lane 12:  Positive control 16 µl 
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Aging Cytosolic heart 
Film Properties Report for ERK1/2 
Experimenter:  Shinichi Asano 
Muscle / Tissue: Cytosolic cardiac muscle            
Species:  F 344/NNia x Brown Norway/BiNia rat 
Protein concentration:  1.5 µg/ml            Gel type:  10% Tris-HCL SDS_PAGE 
Electrophoresis Voltage:  124V Transfer Voltage:  24V Duration:  45 min 
Primary Antibody: ERK1/2 (Cell Signal)  Primary Antibody Dilution:  1/1000 
 Incubation Time:  Overnight @ 4°C  Medium:  5% BSA in TBS-T 
Secondary Antibody:  Anti-Rabbit   Secondary Antibody Dilution:1/1000 
 Incubation Time:  1hr@room temp  Medium:  5% milk in TBS-T 
Exposure Time:  15 seconds    Molecular weight:  42,44 kDa 
Lane 1:  Biotinylated Ladder 16µl 
Lane 2:  Rainbow Marker RPN756 8 µl 
Lane 3:  6month 20 µl 
Lane 4:  6month 20 µl 
Lane 5:  6month 20 µl 
Lane 6:  30month 20 µl 
Lane 7:  30month 20 µl 
Lane 8:  36month 20 µl 
Lane 9:  36month 20 µl 
Lane 10:  36month 20 µl 
Lane 11:  36month 20 µl 
Lane 12:  Positive control 16 µl 
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Aging Cytosolic heart 
Film Properties Report for Phospho-ERK1/2 
Experimenter:  Shinichi Asano 
Muscle / Tissue: Cytosolic cardiac muscle            
Species:  F 344/NNia x Brown Norway/BiNia rat 
Protein concentration:  1.5 µg/ml            Gel type:  10% Tris-HCL SDS_PAGE 
Electrophoresis Voltage:  124V Transfer Voltage:  24V Duration:  45 min 
Primary Antibody: P-Erk1/2 (Cell Signal)  Primary Antibody Dilution:  1/1000 
 Incubation Time:  Overnight @ 4°C  Medium:  5% BSA in TBS-T 
Secondary Antibody:  Anti-Mouse   Secondary Antibody Dilution:1/1000 
 Incubation Time:  1hr@room temp  Medium:  5% milk in TBS-T 
Exposure Time:  1 minutes    Molecular weight:  42, 44 kDa 
Lane 1:  Biotinylated Ladder 16µl 
Lane 2:  Rainbow Marker RPN756 8 µl 
Lane 3:  6month 20 µl 
Lane 4:  6month 20 µl 
Lane 5:  6month 20 µl 
Lane 6:  30month 20 µl 
Lane 7:  30month 20 µl 
Lane 8:  36month 20 µl 
Lane 9:  36month 20 µl 
Lane 10:  36month 20 µl 
Lane 11:  36month 20 µl 
Lane 12:  Positive control 16 µl 
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Aging Cytosolic heart 
Film Properties Report for Nonphospho-Src(Tyr527) 
Experimenter:  Shinichi Asano 
Muscle / Tissue: Cytosolic cardiac muscle            
Species:  F 344/NNia x Brown Norway/BiNia rat 
Protein concentration:  1.5 µg/ml            Gel type:  10% Tris-HCL SDS_PAGE 
Electrophoresis Voltage:  124V Transfer Voltage:  24V Duration:  45 min 
Primary Antibody: Non-p-Src (Cell Signal)  Primary Antibody Dilution:  1/1000 
 Incubation Time:  Overnight @ 4°C  Medium:  5% BSA in TBS-T 
Secondary Antibody:  Anti-Rabbit   Secondary Antibody Dilution:1/1000 
 Incubation Time:  1hr@room temp  Medium:  5% milk in TBS-T 
Exposure Time:  5 minutes    Molecular weight:  60 kDa 
Lane 1:  Biotinylated Ladder 16µl 
Lane 2:  Rainbow Marker RPN756 8 µl 
Lane 3:  6month 20 µl 
Lane 4:  6month 20 µl 
Lane 5:  6month 20 µl 
Lane 6:  30month 20 µl 
Lane 7:  30month 20 µl 
Lane 8:  36month 20 µl 
Lane 9:  36month 20 µl 
Lane 10:  36month 20 µl 
Lane 11:  36month 20 µl 
Lane 12:  Positive control 16 µl 
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Aging Cytosolic heart 
Film Properties Report for Phospho-Src(tyr527) 
Experimenter:  Shinichi Asano 
Muscle / Tissue: Cytosolic cardiac muscle            
Species:  F 344/NNia x Brown Norway/BiNia rat 
Protein concentration:  1.5 µg/ml            Gel type:  10% Tris-HCL SDS_PAGE 
Electrophoresis Voltage:  124V Transfer Voltage:  24V Duration:  45 min 
Primary Antibody: P- Src(tyr527) (Cell Signal) Primary Antibody Dilution:  1/1000 
 Incubation Time:  Overnight @ 4°C  Medium:  5% BSA in TBS-T 
Secondary Antibody:  Anti-Rabbit   Secondary Antibody Dilution:1/1000 
 Incubation Time:  1hr@room temp  Medium:  5% milk in TBS-T 
Exposure Time:  1 minutes    Molecular weight:  60 kDa 
Lane 1:  Biotinylated Ladder 16µl 
Lane 2:  Rainbow Marker RPN756 8 µl 
Lane 3:  6month 20 µl 
Lane 4:  6month 20 µl 
Lane 5:  6month 20 µl 
Lane 6:  30month 20 µl 
Lane 7:  30month 20 µl 
Lane 8:  36month 20 µl 
Lane 9:  36month 20 µl 
Lane 10:  36month 20 µl 
Lane 11:  36month 20 µl 
Lane 12:  Positive control 16 µl 
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Aging Cytosolic heart 
Film Properties Report for Bax 
Experimenter:  Shinichi Asano 
Muscle / Tissue: Cytosolic cardiac muscle            
Species:  F 344/NNia x Brown Norway/BiNia rat 
Protein concentration:  1.5 µg/ml            Gel type:  10% Tris-HCL SDS_PAGE 
Electrophoresis Voltage:  124V Transfer Voltage:  24V Duration:  45 min 
Primary Antibody:  Bax (Santa Cruz)   Primary Antibody Dilution:  1/1000 
 Incubation Time:  1hr @ Room temp  Medium:  5% BSA in TBS-T 
Secondary Antibody:  Anti-Rabbit   Secondary Antibody Dilution:1/1000 
 Incubation Time:  1hr@room temp  Medium:  5% milk in TBS-T 
Exposure Time:  30 seconds    Molecular weight:  23 kDa 
Lane 1:  Biotinylated Ladder 16µl 
Lane 2:  Rainbow Marker RPN756 8 µl 
Lane 3:  6month 20 µl 
Lane 4:  6month 20 µl 
Lane 5:  6month 20 µl 
Lane 6:  30month 20 µl 
Lane 7:  30month 20 µl 
Lane 8:  36month 20 µl 
Lane 9:  36month 20 µl 
Lane 10:  36month 20 µl 
Lane 11:  36month 20 µl 
Lane 12:  Positive control 16 µl 
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Aging Cytosolic heart 
Film Properties Report for Bcl-2 
Experimenter:  Shinichi Asano 
Muscle / Tissue: Cytosolic cardiac muscle            
Species:  F 344/NNia x Brown Norway/BiNia rat 
Protein concentration:  1.5 µg/ml            Gel type:  10% Tris-HCL SDS_PAGE 
Electrophoresis Voltage:  124V Transfer Voltage:  24V Duration:  45 min 
Primary Antibody:  Bcl-s (Santa Cruz)   Primary Antibody Dilution:  1/1000 
 Incubation Time:  1hr @ Room temp  Medium:  5% BSA in TBS-T 
Secondary Antibody:  Anti-Mouse   Secondary Antibody Dilution:1/1000 
 Incubation Time:  1hr@room temp  Medium:  5% milk in TBS-T 
Exposure Time:  4 min    Molecular weight:  26 kDa 
Lane 1:  Biotinylated Ladder 16µl 
Lane 2:  Rainbow Marker RPN756 8 µl 
Lane 3:  6month 20 µl 
Lane 4:  6month 20 µl 
Lane 5:  6month 20 µl 
Lane 6:  30month 20 µl 
Lane 7:  30month 20 µl 
Lane 8:  36month 20 µl 
Lane 9:  36month 20 µl 
Lane 10:  36month 20 µl 
Lane 11:  36month 20 µl 
Lane 12:  Positive control 16 µl 
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Aging Cytosolic heart 
Film Properties Report for traf2 
Experimenter:  Shinichi Asano 
Muscle / Tissue: Cytosolic cardiac muscle            
Species:  F 344/NNia x Brown Norway/BiNia rat 
Protein concentration:  1.5 µg/ml            Gel type:  10% Tris-HCL SDS_PAGE 
Electrophoresis Voltage:  124V Transfer Voltage:  24V Duration:  45 min 
Primary Antibody: traf2 (Santa Cruz)  Primary Antibody Dilution:  1/1000 
 Incubation Time:  Overnight @ 4°C  Medium:  5% BSA in TBS-T 
Secondary Antibody:  Anti-Rabbit   Secondary Antibody Dilution:1/1000 
 Incubation Time:  1hr@room temp  Medium:  5% milk in TBS-T 
Exposure Time:  1 minutes    Molecular weight:  50 kDa 
Lane 1:  Biotinylated Ladder 16µl 
Lane 2:  Rainbow Marker RPN756 8 µl 
Lane 3:  6month 20 µl 
Lane 4:  6month 20 µl 
Lane 5:  6month 20 µl 
Lane 6:  30month 20 µl 
Lane 7:  30month 20 µl 
Lane 8:  36month 20 µl 
Lane 9:  36month 20 µl 
Lane 10:  36month 20 µl 
Lane 11:  36month 20 µl 
Lane 12:  Positive control 16 µl 
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Aging Cytosolic heart 
Film Properties Report for HSP 27 
Experimenter:  Shinichi Asano 
Muscle / Tissue: Cytosolic cardiac muscle            
Species:  F 344/NNia x Brown Norway/BiNia rat 
Protein concentration:  1.5 µg/ml            Gel type:  10% Tris-HCL SDS_PAGE 
Electrophoresis Voltage:  124V Transfer Voltage:  24V Duration:  45 min 
Primary Antibody:  HSP 27 (Santa Cruz)   Primary Antibody Dilution:  1/1000 
 Incubation Time:  1hr @ Room temp  Medium:  5% BSA in TBS-T 
Secondary Antibody:  Anti-Mouse   Secondary Antibody Dilution:1/1000 
 Incubation Time:  1hr@room temp  Medium:  5% milk in TBS-T 
Exposure Time:  4 min    Molecular weight:  27 kDa 
Lane 1:  Biotinylated Ladder 16µl 
Lane 2:  Rainbow Marker RPN756 8 µl 
Lane 3:  6month 20 µl 
Lane 4:  6month 20 µl 
Lane 5:  6month 20 µl 
Lane 6:  30month 20 µl 
Lane 7:  30month 20 µl 
Lane 8:  36month 20 µl 
Lane 9:  36month 20 µl 
Lane 10:  36month 20 µl 
Lane 11:  36month 20 µl 
Lane 12:  Positive control 16 µl 
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Aging Cytosolic heart 
Film Properties Report for HSP 70 
Experimenter:  Shinichi Asano 
Muscle / Tissue: Cytosolic cardiac muscle            
Species:  F 344/NNia x Brown Norway/BiNia rat 
Protein concentration:  1.5 µg/ml            Gel type:  10% Tris-HCL SDS_PAGE 
Electrophoresis Voltage:  124V Transfer Voltage:  24V Duration:  45 min 
Primary Antibody:  HSP 27 (Santa Cruz)   Primary Antibody Dilution:  1/1000 
 Incubation Time:  1hr @ Room temp  Medium:  5% BSA in TBS-T 
Secondary Antibody:  Anti-Goat   Secondary Antibody Dilution:1/1000 
 Incubation Time:  1hr@room temp  Medium:  5% milk in TBS-T 
Exposure Time:  10 min    Molecular weight:  70 kDa 
Lane 1:  Biotinylated Ladder 16µl 
Lane 2:  Rainbow Marker RPN756 8 µl 
Lane 3:  6month 20 µl 
Lane 4:  6month 20 µl 
Lane 5:  6month 20 µl 
Lane 6:  30month 20 µl 
Lane 7:  30month 20 µl 
Lane 8:  36month 20 µl 
Lane 9:  36month 20 µl 
Lane 10:  36month 20 µl 
Lane 11:  36month 20 µl 
Lane 12:  Positive control 16 µl 
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Aging Cytosolic heart 
Film Properties Report for Nitro-Tyrosine 
Experimenter:  Shinichi Asano 
Muscle / Tissue: Cytosolic cardiac muscle            
Species:  F 344/NNia x Brown Norway/BiNia rat 
Protein concentration:  1.5 µg/ml            Gel type:  10% Tris-HCL SDS_PAGE 
Electrophoresis Voltage:  124V Transfer Voltage:  24V Duration:  45 min 
Primary Antibody: Nitro-Tyrosine (Cell Signal) Primary Antibody Dilution:  1/1000 
 Incubation Time:  1hr @ Room temp  Medium:  5% BSA in TBS-T 
Secondary Antibody:  Anti-Rabbit   Secondary Antibody Dilution:1/1000 
 Incubation Time:  1hr@room temp  Medium:  5% milk in TBS-T 
Exposure Time:  15 seconds    Molecular weight:    
Lane 1:  Biotinylated Ladder 16µl 
Lane 2:  Rainbow Marker RPN756 8 µl 
Lane 3:  6month 20 µl 
Lane 4:  6month 20 µl 
Lane 5:  6month 20 µl 
Lane 6:  30month 20 µl 
Lane 7:  30month 20 µl 
Lane 8:  36month 20 µl 
Lane 9:  36month 20 µl 
Lane 10:  36month 20 µl 
Lane 11:  36month 20 µl 
Lane 12:  Positive control 16 µl 
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Aging Cytosolic heart 
Film Properties Report for NFkB p50   
Experimenter:  Shinichi Asano 
Muscle / Tissue: Cytosolic cardiac muscle            
Species:  F 344/NNia x Brown Norway/BiNia rat 
Protein concentration:  1.5 µg/ml            Gel type:  10% Tris-HCL SDS_PAGE 
Electrophoresis Voltage:  124V Transfer Voltage:  24V Duration:  45 min 
Primary Antibody: NFkB p50  (Santa Cruz)  Primary Antibody Dilution:  1/1000 
 Incubation Time:  Overnight @ 4°C  Medium:  5% BSA in TBS-T 
Secondary Antibody:  Anti-Mouse   Secondary Antibody Dilution:1/1000 
 Incubation Time:  1hr@room temp  Medium:  5% milk in TBS-T 
Exposure Time:  Touch and go   Molecular weight:  50 kDa 
Lane 1:  Biotinylated Ladder 16µl 
Lane 2:  Rainbow Marker RPN756 8 µl 
Lane 3:  6month 20 µl 
Lane 4:  6month 20 µl 
Lane 5:  6month 20 µl 
Lane 6:  30month 20 µl 
Lane 7:  30month 20 µl 
Lane 8:  36month 20 µl 
Lane 9:  36month 20 µl 
Lane 10:  36month 20 µl 
Lane 11:  36month 20 µl 
Lane 12:  Positive control 16 µl 
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Aging Cytosolic heart 
Film Properties Report for NF-Kβ p65 
Experimenter:  Shinichi Asano 
Muscle / Tissue: Cytosolic cardiac muscle            
Species:  F 344/NNia x Brown Norway/BiNia rat 
Protein concentration:  1.5 µg/ml            Gel type:  10% Tris-HCL SDS_PAGE 
Electrophoresis Voltage:  124V Transfer Voltage:  24V Duration:  45 min 
Primary Antibody: NF-Kβ p65(Cell Signal) Primary Antibody Dilution:  1/1000 
 Incubation Time:  Overnight @ 4°C  Medium:  5% BSA in TBS-T 
Secondary Antibody:  Anti-Rabbit   Secondary Antibody Dilution:1/1000 
 Incubation Time:  1hr@room temp  Medium:  5% milk in TBS-T 
Exposure Time:  1 hour    Molecular weight:  65 kDa 
Lane 1:  Biotinylated Ladder 16µl 
Lane 2:  Rainbow Marker RPN756 8 µl 
Lane 3:  6month 20 µl 
Lane 4:  6month 20 µl 
Lane 5:  6month 20 µl 
Lane 6:  30month 20 µl 
Lane 7:  30month 20 µl 
Lane 8:  36month 20 µl 
Lane 9:  36month 20 µl 
Lane 10:  36month 20 µl 
Lane 11:  36month 20 µl 
Lane 12:  Positive control 16 µl 
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Aging Cytosolic heart 
Film Properties Report for Phospho-NF-Kβ p65 
Experimenter:  Shinichi Asano 
Muscle / Tissue: Cytosolic cardiac muscle            
Species:  F 344/NNia x Brown Norway/BiNia rat 
Protein concentration:  1.5 µg/ml            Gel type:  10% Tris-HCL SDS_PAGE 
Electrophoresis Voltage:  124V Transfer Voltage:  24V Duration:  45 min 
Primary Antibody: P- NF-Kβ p65(Cell Signal) Primary Antibody Dilution:  1/1000 
 Incubation Time:  Overnight @ 4°C  Medium:  5% BSA in TBS-T 
Secondary Antibody:  Anti-Rabbit   Secondary Antibody Dilution:1/1000 
 Incubation Time:  1hr@room temp  Medium:  5% milk in TBS-T 
Exposure Time:  1hour    Molecular weight:  65 kDa 
Lane 1:  Biotinylated Ladder 16µl 
Lane 2:  Rainbow Marker RPN756 8 µl 
Lane 3:  6month 20 µl 
Lane 4:  6month 20 µl 
Lane 5:  6month 20 µl 
Lane 6:  30month 20 µl 
Lane 7:  30month 20 µl 
Lane 8:  36month 20 µl 
Lane 9:  36month 20 µl 
Lane 10:  36month 20 µl 
Lane 11:  36month 20 µl 
Lane 12:  Positive control 16 µl 
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